Charles River Laboratories | CRL - Vermögenswerte

Aktienkurs
169.80
Täglich Wechseln
2.06 1.23%
Monatlich
2.36%
Jährlich
48.09%
Q2 Prognose
166.17




Vermögenswerte Veränderung Datum
Agilent USD 12.81B 86M 2025-12
Align Technology USD 6.23B 141K 2025-12
Bio-Rad Laboratories USD 10.58B 880.1M 2025-12
Bruker USD 6.24B 193.5M 2025-12
Cardinal Health USD 58.08B 2.86B 2025-12
Charles River Laboratories USD 7.14B 378.39M 2025-12
Cigna USD 157.92B 0 2025-12
Concord Medical Services Hldg CNY 6.73B 663.4M 2025-06
CVS Health USD 253.54B 1.79B 2025-12
Danaher USD 83.54B 80M 2026-03
Dentsply International USD 5.43B 224M 2025-12
Elevance Health USD 125.83B 4.33B 2026-03
Galapagos EUR 3.41B 105.39M 2025-12
Humana USD 48.91B 810M 2025-12
Illumina USD 6.64B 467M 2025-12
Incyte USD 6.96B 627.62M 2025-12
Intrexon USD 73.16M 77.88M 2024-06
IQVIA Holdings USD 29.94B 1.22B 2025-12
Laboratory Of America USD 18.39B 131.1M 2025-12
Lonza CHF 18.97B 164M 2025-12
McKesson USD 84.19B 30M 2025-12
Merck EUR 51.53B 600M 2025-12
Mettler Toledo International USD 3.71B 191.18M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Quest Diagnostics USD 16.67B 448M 2026-03
Revvity USD 12.17B 29.46M 2025-12
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
United Therapeutics USD 7.88B 528.9M 2025-12
UnitedHealth USD 312.64B 3.06B 2026-03
Veradigm USD 1.5B 185.94M 2022-12
Waters USD 5.08B 221.41M 2025-12
West Pharmaceutical Services USD 4.11B 160.2M 2026-03